GB1412202A - Purification of glycoproteins - Google Patents

Purification of glycoproteins

Info

Publication number
GB1412202A
GB1412202A GB753073A GB753073A GB1412202A GB 1412202 A GB1412202 A GB 1412202A GB 753073 A GB753073 A GB 753073A GB 753073 A GB753073 A GB 753073A GB 1412202 A GB1412202 A GB 1412202A
Authority
GB
United Kingdom
Prior art keywords
glycoproteins
purification
feb
heading
chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB753073A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1412202A publication Critical patent/GB1412202A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB753073A 1972-02-15 1973-02-15 Purification of glycoproteins Expired GB1412202A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7205016A FR2171907B2 (sv) 1972-02-15 1972-02-15

Publications (1)

Publication Number Publication Date
GB1412202A true GB1412202A (en) 1975-10-29

Family

ID=9093508

Family Applications (1)

Application Number Title Priority Date Filing Date
GB753073A Expired GB1412202A (en) 1972-02-15 1973-02-15 Purification of glycoproteins

Country Status (12)

Country Link
JP (2) JPS4896792A (sv)
BE (1) BE795417A (sv)
CA (1) CA993389A (sv)
CH (1) CH564084A5 (sv)
DE (1) DE2307051C3 (sv)
DK (1) DK146724C (sv)
ES (1) ES411602A2 (sv)
FR (1) FR2171907B2 (sv)
GB (1) GB1412202A (sv)
HU (1) HU168849B (sv)
NL (1) NL174267C (sv)
SE (1) SE425833B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
IT1199301B (it) * 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
CH699786A2 (fr) * 2008-10-31 2010-05-14 Marie-Christine Dr Etienne Médicament déstiné à traiter des infections.

Also Published As

Publication number Publication date
JPS59219236A (ja) 1984-12-10
ES411602A2 (es) 1976-03-01
HU168849B (sv) 1976-07-28
NL174267C (nl) 1984-05-16
JPS6028813B2 (ja) 1985-07-06
CA993389A (fr) 1976-07-20
SE425833B (sv) 1982-11-15
JPS4896792A (sv) 1973-12-10
DE2307051B2 (de) 1979-10-04
FR2171907A2 (sv) 1973-09-28
FR2171907B2 (sv) 1975-04-25
DK146724C (da) 1984-05-28
NL7302132A (sv) 1973-08-17
CH564084A5 (sv) 1975-07-15
BE795417A (fr) 1973-08-14
DE2307051A1 (de) 1973-08-23
DK146724B (da) 1983-12-12
DE2307051C3 (de) 1980-06-19

Similar Documents

Publication Publication Date Title
AU459399B2 (en) Improvements in or relating tothe production of enzyme preparations
AU468839B2 (en) Improvements in or relating to eartags
AU458633B2 (en) Improvements relating to vehicle-wheel suspension systems
GB1412202A (en) Purification of glycoproteins
AU6837674A (en) Improvements in or relating to failsafe driver
GB1369185A (en) Process for the production of fructose
AU475470B2 (en) Improvements in or relating to fastening means
IE38057B1 (en) Improvements in or relating to tyres
AU450435B2 (en) Improvements in or relating to vehicle suspension systems
GB1450425A (en) Process for the manufacture of beta-3-oxo-7alpha-acetylthio- 17beta-hydroxy-4-androsten-17alpha-yl- -propionic acid ypsilon- lactone and an intermediate in its production
GB1177506A (en) Improvements relating to Anticoagulants.
Cordell Richardson The Identification by Voice of Speakers Belonging to Two Ethnic Groups
CA844001A (en) Process of producing 2,6-diphenylphenol
CA845738A (en) Process for purifying 4,4'-isopropylidenediphenol
AU5203369A (en) Improvements relating to semipermeable membranes
AU424554B2 (en) Improvements in or relating tothe process of producing butanals by oxo synthesis, and its application tothe manufacture of ethylhexanol
CA980786A (en) N-acyl-n'-substituted-2,6-diaminobenzoic acid derivatives
CA840980A (en) Fermentation method for producing 5'-purine nucleotides
AU3819268A (en) Improvements relating to sails, driving means and boats incorporating same
AU481217B2 (en) Improvements in or relating to amplifiers
CA816687A (en) Process for producing guanosine-5'-monophosphate by fermentation
AU478277B2 (en) Improvements in or relating to crossed bar windows adjusting arrangements
AU461784B2 (en) Improvements in or relating to the production of enzyme preparations
AU440571B2 (en) Semipermeable membranes
CA811146A (en) PROCESS FOR PREPARING 17.alpha.-HALOETHYNYL-ESTRA-4,9-DIENES AND INTERMEDIATES

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]